MCTIC
MRK icon

MacGuire Cheswick & Tuttle Investment Counsel’s Merck MRK Stock Holding History

MacGuire Cheswick & Tuttle Investment Counsel’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$8.37M Buy
114,753
+3,747
+3% +$265K 1.75% 19
2018
Q3 		$7.51M Buy
111,006
+3,233
+3% +$206K 1.29% 31
2018
Q2 		$6.24M Buy
107,773
+3,275
+3% +$185K 1.15% 34
2018
Q1 		$5.43M Sell
104,498
-262
-0.3% -$14.2K 1.01% 37
2017
Q4 		$5.63M Sell
104,760
-4,206
-4% -$233K 1.02% 37
2017
Q3 		$6.66M Buy
108,966
+3,432
+3% +$208K 1.31% 31
2017
Q2 		$6.45M Sell
105,534
-9,222
-8% -$561K 1.31% 30
2017
Q1 		$6.96M Buy
114,756
+964
+0.8% +$58.5K 1.35% 32
2016
Q4 		$6.39M Buy
113,792
+5,266
+5% +$308K 1.32% 36
2016
Q3 		$6.46M Buy
108,526
+785
+0.7% +$45.9K 1.45% 30
2016
Q2 		$5.92M Buy
107,741
+787
+0.7% +$41.9K 1.32% 34
2016
Q1 		$5.4M Sell
106,954
-3,500
-3% -$171K 1.26% 32
2015
Q4 		$5.57M Buy
110,454
+314
+0.3% +$15.8K 1.25% 33
2015
Q3 		$5.19M Buy
110,140
+4,633
+4% +$246K 1.27% 34
2015
Q2 		$5.73M Buy
105,507
+241
+0.2% +$13.5K 1.28% 32
2015
Q1 		$5.77M Sell
105,266
-786
-0.7% -$44.5K 1.3% 30
2014
Q4 		$5.75M Buy
106,052
+733
+0.7% +$40.8K 1.29% 31
2014
Q3 		$5.96M Buy
105,319
+189
+0.2% +$10.6K 1.39% 30
2014
Q2 		$5.8M Buy
105,130
+3,039
+3% +$166K 1.35% 32
2014
Q1 		$5.53M Buy
102,091
+2,259
+2% +$117K 1.34% 31
2013
Q4 		$4.77M Sell
99,832
-30,899
-24% -$1.41M 1.15% 33
2013
Q3 		$5.94M Sell
130,731
-148
-0.1% -$6.76K 1.63% 27
2013
Q2 		$5.8M Buy
+130,879
New +$5.85M 1.66% 26

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MacGuire Cheswick & Tuttle Investment Counsel's MRK Position: Q4 2018 in Review

MacGuire Cheswick & Tuttle Investment Counsel increased its Merck (MRK) stake by 3.4% in Q4 2018, buying an estimated $265K and bringing the position to 114,753 shares worth $8.37M. The position accounts for 1.75% of the portfolio, ranked #19.

MacGuire Cheswick & Tuttle Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 23 quarters since. 2,251 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • MacGuire Cheswick & Tuttle Investment Counsel held 114,753 shares of Merck worth $8.37M as of Q4 2018.
  • MacGuire Cheswick & Tuttle Investment Counsel bought 3,747 Merck shares in Q4 2018, an estimated $265K.
  • Merck made up 1.75% of MacGuire Cheswick & Tuttle Investment Counsel's portfolio in Q4 2018, its #19 holding.
  • MacGuire Cheswick & Tuttle Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 23 quarters since.
  • 2,251 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on MacGuire Cheswick & Tuttle Investment Counsel's 13F filing for Q4 2018, filed 11 Feb 2019.